Mizuho cuts EyePoint to neutral from outperform, target to $0.50 from $39
EYPT•Mizuho cut its rating on EyePoint to neutral from outperform and lowered its target price to $0.50 from $39.
Related News
MSCI Q3 adjusted EPS rises, beats estimates
MSCI•
Copper tube maker Mueller Industries' Q3 revenue rises on higher volumes
MLI•
Olin Corp: Truist Securities cuts target price to $15 from $20
OLN•
Visara secures exclusive option for potential acquisition of YOL104-2 for ocular surface squamous neoplasia
NBP•
Teck Resources target price raised to C$95 from C$80
TECK•